Literature DB >> 7952127

Liquid chromatographic determination of the adenosine receptor agonist CGS 21680 in blood using on-line solid-phase extraction on a phenylboronic acid support and fluorescence detection.

H Irth1, A Cleton, R A Mathôt, M Danhof, A P IJzerman, U R Tjaden, J van der Greef.   

Abstract

An analytical method is described for the selective determination of A1 or A2 adenosine receptor agonists in blood. By implementing solid-phase extraction using immobilized-phenylboronic acid (PBA) in sample pretreatment, all adenosine derivatives are retained via their intact cis-diol group. On-line desorption of the analytes from the PBA support to the C18 analytical column is performed by injection of a small plug of perchloric acid. Fluorescence and UV detection are employed for the different adenosine derivatives. The method is applied to the determination of 2-[p-(2-carboxyethyl)phenylethylamino]-5'-N- ethylcarboxyamidoadenosine (CGS 21680, I) in blood using fluorescence detection. The only off-line sample handling step is the extraction of blood with ethyl acetate and subsequent evaporation of the extraction solvent. The detection limit of the method was 0.25 ng (signal-to-noise ratio 3:1) and the determination limit for I in blood (pretreatment of 100 microliters) was 5 ng/ml. The method was validated and used to study the pharmacokinetics of I in rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952127     DOI: 10.1016/0378-4347(94)00216-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  2 in total

1.  Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats.

Authors:  R A Mathôt; A Cleton; W Soudijn; A P IJzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

2.  Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.

Authors:  R A Mathôt; J M Gubbens-Stibbe; W Soudijn; K A Jacobson; A P Ijzerman; M Danhof
Journal:  J Pharmacol Exp Ther       Date:  1995-10       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.